Skip to main content
. 2022 Oct 24;14(11):2271. doi: 10.3390/pharmaceutics14112271

Table 1.

Characterization of MNPs 114.

MNPs Components Relative Content of Inorganic Elements (%) 1 EA Data (%) Inorganic Component Ratio Concentration of Organic Components (mmol/g) MS (emu/g)
PMIDA TEOS (Equiv.) APTMS (Equiv.) Fe Si P C SiO2:Fe3O4 2 SSi–O/SFe–O 3 CAPS 4 CPMIDA 5
1 100 0 0 0 0 0 74
2 + 94.34 0 5.66 5.85 0 0.97 61
3 1.5 77.12 22.88 0 0 31:69 2.33 0 0 51
4 3.0 64.08 35.92 0 0 46:54 3.86 0 0 39
5 5.0 50.78 49.22 0 0 60:40 6.61 0 0 26
6 + 1.5 71.32 24.87 3.80 1.72 35:65 3.56 0 0.63 40
7 + 3.0 57.13 39.93 2.94 1.18 52:48 6.13 0 0.49 28
8 + 5.0 46.38 51.74 1.87 1.00 63:37 13.05 0 0.31 21
9 1.5 3.0 74.65 25.35 0 3.49 34:66 4.18 0.48 0 49
10 3.0 3.0 63.46 36.54 0 2.71 47:53 7.73 0.32 0 38
11 5.0 3.0 50.34 49.66 0 1.80 60:40 13.34 0.28 0 27
12 + 1.5 3.0 68.82 29.69 1.49 4.31 40:60 3.97 0.66 0.26 37
13 + 3.0 3.0 57.27 41.50 1.23 2.63 47:53 7.58 0.33 0.21 28
14 + 5.0 3.0 45.70 53.29 1.01 2.03 64:36 13.04 0.34 0.17 21

1 EDX data. 2 Calculated from the EDX data by analogy with [27]. 3 Calculated from the FTIR spectra. 4 Calculated based on the CHN-elemental analysis data by analogy with [78]. 5 Calculated from the EDX data.